CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±èÀ¯½Å
  • ¼Ò ¼Ó: Â÷¿©¼ºÀÇÇבּ¸¼Ò ¼­¿ï¿ª¼¾ÅÍ
  • Àü¹®ºÐ¾ß : ½ÃÇè°ü, ¹Ì¼º¼÷ ½ÃÇè°ü, ¹Ýº¹½ÇÆÐ ¹× Àú¹ÝÀÀ±º ½ÃÇè°ü, PGT, ´ÙºóÄ¡ ·Îº¿ ¹× ¹Ì¼¼ º¹°­°æ ¼ö¼ú
  • Á÷ À§: ±³¼ö
  • ¸Þ ÀÏ: .
  • Àü È­: 02-2002-0300
  • ÆÑ ½º:
  • ÁÖ ¼Ò: ¼­¿ï½Ã Áß±¸ ÇÑ°­´ë·Î 416 ¼­¿ï½ºÄù¾î 2Ãþ Â÷º´¿ø ¿©¼ºÀÇÇבּ¸¼Ò ¼­¿ï¿ª¼¾ÅÍ
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

Àü¹®ºÐ¾ß

  • ¹Ì¼º¼÷³­ÀÚ½ÃÇè°ü(IVM), ´Ù³¶¼º ³­¼ÒÁõÈıº, Davinci Robot, º¹°­°æ¡¤Àڱð格ö¼ú, PGD/PGS

Áø·áÀÏÁ¤

ÇÐÀ§ ¹× °æ·Â

[±³¼ö °æ·Â]
  • Â÷ÀÇ°úÇдëÇб³





  • [Áø·á °æ·Â]
  • Â÷ÀÇ°úÇдëÇб³ °­³²Â÷º´¿ø ±³À°¼ö·Ã ºÎÀå

  • Â÷ÀÇ°úÇдëÇб³ Â÷ ¿©¼ºÀÇÇבּ¸¼Ò ¼­¿ï¿ª Áø·áºÎÀå

  • Â÷ÀÇ°úÇдëÇб³ Â÷ ¿©¼ºÀÇÇבּ¸¼Ò ¼­¿ï¿ª Áø·áºÎ¿øÀå





  • [ÇÐȸ¡¤¿¬±¸¡¤¿¬¼ö¡¤¼ö»ó °æ·Â]
  • ´ëÇÑ »ý½ÄÀÇÇÐȸ »ç¹«ÃÑÀå

  • ´ëÇÑ »ý½Ä ¸é¿ªÇÐȸ ÀÓ»óÀ§¿øÀå

  • ´ëÇÑ »êºÎÀΰúÇÐȸ ½É»çÀ§¿ø

  • ´ëÇÑ »ý½ÄÀÇÇÐȸ ÇмúÀ§¿ø

  • ´ëÇÑ º¸Á¶»ý½ÄÇÐȸ ÇмúÀ§¿ø

  • ´ëÇÑ »êºÎÀΰú ÇÐȸ Á¤È¸¿ø

  • À¯·´ »ý½ÄÀÇÇÐȸ Á¤È¸¿ø

  • ¹Ì±¹ »ý½ÄÀÇÇÐȸ Á¤È¸¿ø

  • [³í¹®]
  • 1.Freeze all-first versus biopsy-first: A retrospective analysis of frozen blastocyst transfer cycles with preimplantation genetic testing for aneuploidy. Plos one 2022.

  • 2.Microtubule Integrity Is Associated with the Functional Activity of Mitochondria in HEK293 2021.12.18. Cells 2073-4409 doi.org/10.3390/cells10123600

  • 3.Upregulation of Low-density lipoprotein receptor of the steroidogenesis pathway in the cumulus cells is associated with the maturation of oocytes and achievement of pregnancy. 2021.9.10. Cells Vol 10 .No 9

  • 4.Land use and semen quality: A fertility center cohort study. PlosOne 10.1371/journal.pone.0255985 2021.8.12.

  • 5.The Effect of Additional Embryo Transfer on the Pregnancy Rate in Young Women Receiving in vitro Fertilization: A Natural Experiment Study. International journal of women. Vol 13 ,No 1 ,379-384

  • 6.The mitochondrial-derived peptide MOTS-c promotes homeostasis in aged humanp lacenta-derived mesenchymal stem cells in vitro.Mitochondrion.2021.2.12. Vol58,No11,135-146

  • 7.Nighttime environmental noise and semen quality: A single fertility center cohort study.PloS one,10.1371/journal.pone.0240689.2020.9.30.

  • 8.Peripheral blood natural killer cell proportion and ovarian function in women with recurrent implantation failure. Gynecol Endocrinol.10.1080/09513590.2020.1725969.2020.2.2

  • 9.Outcomes of in vitro fertilization cycles following fertility sparing treatment in stage IA endometrial cancer.Archives of gynecology and obstetrics. 2019.6.28.10.1007/s00404-019-05237-2

  • 10.Decision making processes of women who seek elective oocyte cryopreservation.Journal of assisted reproduction and genetics. Vol 35.No9.1623-1630.2018.6.29.

  • 11.Predictive value of antral follicle count and serum anti-Mullerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment? Eur J Obstet Gynecol Reprod Biol. vol21( 151-155)2017.12.26.

  • 12.Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study. Arch Gynecol Obstet.Vol 29. 791-796.2017.9.19

  • 13.Therapeutic outcomes of methotrexate injection in unruptured interstitial pregnancy.Obstetrics & gynecology science. vol 60.No6.571-578.2017.6.20

  • 14.Chronic endometritis and infertility.Clin Exp Reprod Med. vol43.No4.185-192 2016.6.30.

  • 15.Successful management of heterotopic cornual pregnancy with laparoscopic cornual resection.Eur J Obstet Gynecol Reprod Biol.2016.8.15.Vol 203 199-203

  • 16.Application of serum anti-M?lerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment.Clin Exp Reprod Med. 2016.6.1. vol43,No2 126-132

  • 17.Association between sex steroids, ovarian reserve, and vitamin d levels in healthy nonobese women.J Clin Endocrinol Metab.2014.7.1.vol99.No7 .2526-2532

  • 18.Impact on ovarian reserve after laparoscopic ovarian cystectomy with reduced port number: a randomized controlled trial.Eur J Obstet Gynecol Reprod Biol.10.1016/j.ejogrb.2014.02.025.2014.2.9.

  • 19.Molecular genetic and cytogenetic characterization of a partial Xp duplication and Xq deletion in a patient with premature ovarian failure.Gene.2013.6.8.Vol534.No1.54-59

  • 20.Combined medroxyprogesterone acetate (MPA)/Levonorgestrel-intrauterine system (LNG-IUS) treatment in young women with early-stage endometrial cancer.Am J Obstet Gynecol.2013.6.17.Vol209,No4.358

  • 21.Evaluation of sperm deoxyribonucleic acid (DNA) damage and effects on embryo development using a mouse cryptorchidism model.Urology.2013.9.1.Vol82,No9.743e17-e 23 .

  • 22.Transcriptional profiling with a pathway-oriented analysis in the placental villi of unexplained miscarriage.Placenta,2013.vo34/No133

  • 23.Does supplementation of in-vitro culture medium with melatonin improve IVF outcome in PCOS?Reprod Biomed Online.2012.10.2.10.1016/j.rbmo.2012.10.007.

  • 24.Recombinant human phospholipase C zeta 1 induces intracellular calcium oscillations and oocyte activation in mouse and human oocytes.Human reproduction (Oxford, England) 2012.6.1vol27. No6

  • 25.Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization.J Assist Reprod Genet 2012. vol29.225-230

  • 26.Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation.J Assist Reprod Genet. 2011.

  • 27.High sensitivity C-reactive protein and its relationship with impaired glucose regulation in lean patients with polycystic ovary syndrome.Gynecol Endocrinol. vol 28 No 4.259-263

  • 28.Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes.J Assist Reprod Genet vol28 . 369-374

  • 29.Effects of various combinations of cryoprotectants and cooling speed on the survival and further development of mouse oocytes after vitrification.Clin Exp Reprod Med. Vol 38. 24-30.

  • 30.Chromosomal abnormalities in spontaneous abortion after assisted reproductive treatment. vol 11. No 11,153

  • Copyright ¨Ï chamc, All rights reserved.

    ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

    • °­³²Â÷º´¿ø
    • ºÐ´çÂ÷º´¿ø
    • ºÐ´çÂ÷¿©¼ºº´¿ø
    • ±¸¹ÌÂ÷º´¿ø
    • ¿©¼ºÀÇÇבּ¸¼Ò
    • Â÷¿ò

    ÀüÈ­¹®ÀÇ

    • °­³²Â÷º´¿ø 02.3468.3000
    • ºÐ´çÂ÷º´¿ø 031.780.5000
    • Â÷¿ò 02.3015.5300
    • ±¸¹ÌÂ÷º´¿ø 054.450.9700
    • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
    • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
    • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
    • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
    • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
    • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729